Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP675963.RAp5iiUw8h8oGGI-YYvB6gemvnK7s5ovjnDaewu5QAWBQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP675963.RAp5iiUw8h8oGGI-YYvB6gemvnK7s5ovjnDaewu5QAWBQ130_assertion type Assertion NP675963.RAp5iiUw8h8oGGI-YYvB6gemvnK7s5ovjnDaewu5QAWBQ130_head.
- NP675963.RAp5iiUw8h8oGGI-YYvB6gemvnK7s5ovjnDaewu5QAWBQ130_assertion description "[The primary objective of this study was to determine the relationship of a HOXB13-to-IL17BR ratio with tumor aggressiveness and/or with response to tamoxifen therapy in estrogen receptor (ER) -positive disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP675963.RAp5iiUw8h8oGGI-YYvB6gemvnK7s5ovjnDaewu5QAWBQ130_provenance.
- NP675963.RAp5iiUw8h8oGGI-YYvB6gemvnK7s5ovjnDaewu5QAWBQ130_assertion evidence source_evidence_literature NP675963.RAp5iiUw8h8oGGI-YYvB6gemvnK7s5ovjnDaewu5QAWBQ130_provenance.
- NP675963.RAp5iiUw8h8oGGI-YYvB6gemvnK7s5ovjnDaewu5QAWBQ130_assertion SIO_000772 17308270 NP675963.RAp5iiUw8h8oGGI-YYvB6gemvnK7s5ovjnDaewu5QAWBQ130_provenance.
- NP675963.RAp5iiUw8h8oGGI-YYvB6gemvnK7s5ovjnDaewu5QAWBQ130_assertion wasDerivedFrom befree-20140225 NP675963.RAp5iiUw8h8oGGI-YYvB6gemvnK7s5ovjnDaewu5QAWBQ130_provenance.
- NP675963.RAp5iiUw8h8oGGI-YYvB6gemvnK7s5ovjnDaewu5QAWBQ130_assertion wasGeneratedBy ECO_0000203 NP675963.RAp5iiUw8h8oGGI-YYvB6gemvnK7s5ovjnDaewu5QAWBQ130_provenance.